Ovid Therapeutics Inc. · NASDAQ:OVID
BlackRock, Inc.'s stake in Ovid Therapeutics Inc. fell to 1.90% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc.'s stake in Ovid Therapeutics Inc. fell to 1.90%, 1,369,010 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 1.90%
- Shares
- 1,369,010
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.90% | 1,369,010 |
Source
Related
- Ovid Therapeutics Inc.
- BlackRock, Inc.
- Ovid Therapeutics Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026